miRNAs and ovarian cancer: An overview.
Bornali DebArif UddinSupriyo ChakrabortyPublished in: Journal of cellular physiology (2017)
Ovarian cancer (OC) is the sixth most common cancer in women globally. However, even with the advances in detection and therapeutics it still represents the most dangerous gynecologic malignancy in women of the industrialized countries. The discovery of micro-RNAs (miRNA), a small noncoding RNA molecule targeting multiple mRNAs and regulation of gene expression by triggering translation repression and/or RNA degradation, has revealed the existence of a new array for regulation of genes involved in cancer. This review summarizes the current knowledge regarding the role of miRNAs expression in OC. It also provides information about potential clinical relevance of circulating miRNAs for OC diagnosis, prognosis, and therapeutics. The identification of functional targets for miRNAs represents a major obstacle in our understanding of microRNA function in OC, but significant progress is being made. The better understanding of the role of microRNA expression in ovarian cancer may provide new array for the detection, diagnosis, and therapy of the OC.
Keyphrases
- gene expression
- papillary thyroid
- poor prognosis
- small molecule
- polycystic ovary syndrome
- high throughput
- squamous cell
- high resolution
- healthcare
- loop mediated isothermal amplification
- dna methylation
- pregnancy outcomes
- label free
- binding protein
- type diabetes
- long non coding rna
- squamous cell carcinoma
- childhood cancer
- mesenchymal stem cells
- adipose tissue
- insulin resistance
- pregnant women
- risk assessment
- bone marrow
- climate change
- social media
- endometrial cancer
- cell therapy